<clinical_study>
<study_id>
<org_name>
  AghaiSophia
</org_name>
<org_full_name>
  Aghia Sophia Children&apos;s Hospital of Athens
</org_full_name>
<org_study_id>
  12-01-07
</org_study_id>
<nct_id>

</nct_id>
</study_id>
<is_fda_regulated>
  No
</is_fda_regulated>
<brief_title>
<textblock>
  Adenoidectomy, Myringotomy and Tubes&apos; Insertion vs Adenoidectomy and Myringotomy Alone in Children With Otitis Media With Effusion and Adenoid Hypertrophy
</textblock>
</brief_title>
<official_title>
<textblock>
  Adenoidectomy, Myringotomy and Tubes&apos; Insertion vs Adenoidectomy and Myringotomy Alone in Children With Otitis Media With Effusion and Adenoid Hypertrophy
</textblock>
</official_title>
<study_sponsor>
<lead_sponsor>
<agency>
  Aghia Sophia Children&apos;s Hospital of Athens
</agency>
</lead_sponsor>
</study_sponsor>
<resp_party>
<name_title>
  Ioannis Vlastos
</name_title>
<organization>
  Aghia Sophia Children&apos;s Hospital of Athens
</organization>
</resp_party>
<oversight_info>
<regulatory_authority>
  Greece: Ministry of Health and Welfare
</regulatory_authority>
</oversight_info>
<brief_summary>
<textblock>
  It is not unusual for several children operated for severe adenoid hyperthrophy causing breathing problems to have otitis media with effusion simultaneously. It is unknown whether adenoidectomy, myringotomy and tubes insertion is superior to adenoidectomy and myringotomy alone in terms of otitis media related quality of life and recurrence of otitis media several months after the operation. For this purpose a randomized trial is conducted including children operated for adenoid hyperthrophy and whose otitis media with effusion had caused minimal or no symptoms so far
</textblock>
</brief_summary>
<detailed_descr>
<textblock>
</textblock>
</detailed_descr>
<status_block>
<status>
  Recruiting
</status>
<date>
  2008-02
</date>
</status_block>
<start_date>
<date>
  2007-09
</date>
</start_date>
<end_date>
<date>
</date>
</end_date>
<last_follow_up_date>
<date>
</date>
</last_follow_up_date>
<primary_compl_date
 type="Anticipated"
>
<date>
  2008-12
</date>
</primary_compl_date>
<phase_block>
<phase>
  Phase 2
</phase>
</phase_block>
<study_type>
  Interventional
</study_type>
<design>
  Treatment
</design>
<design>
  Randomized
</design>
<design>
  Single Blind (Outcomes Assessor)
</design>
<design>
  Active Control
</design>
<design>
  Parallel Assignment
</design>
<design>
  Efficacy Study
</design>
<number_of_arms>
1 
</number_of_arms>
<primary_outcome>
<measure>
  OM-6
</measure>
<time_frame>
  one year post operative
</time_frame>
<safety_issue>
  No
</safety_issue>
</primary_outcome>
<secondary_outcome>
<measure>
  tympanogram type B
</measure>
<time_frame>
  one year
</time_frame>
<safety_issue>
  No
</safety_issue>
</secondary_outcome>
<enrollment
 type="Anticipated"
>
  40
</enrollment>
<condition>
  Otitis Media With Effusion
</condition>
<arm_group>
<arm_group_label>
  A-T
</arm_group_label>
<arm_type>
  Active Comparator
</arm_type>
<description>
<textblock>
</textblock>
</description>
</arm_group>












<intervention>
<intervent_type>
  Procedure/Surgery
</intervent_type>
<primary_name>
  adenoidectomy, myringotomy, tubes insertion
</primary_name>
<description>
<textblock>
  adenoidectomy, myringotomy and tubes insertion (A-T)against adenoidectomy and myringotomy alone (A-M)
</textblock>
</description>
<arm_group_label>
  A-T
</arm_group_label>
</intervention>
















<eligibility>
<criteria>
<textblock>
  Inclusion Criteria:
    - children operated for their adenoid hyperthrophy with an adenoid size of 3 (measured in a scale of 1-3 intraoperatively or from lateral neck x-ray) and otitis media with effusion causing an average air-bone gap of greater than 20db. Children should be otherwise healthy with an ASA score of I and between 3-12 years old of age
 
  Exclusion Criteria:
    - other health problems especially related with the condition eg cleft palate
</textblock>
</criteria>
<healthy_volunteers>
  No
</healthy_volunteers>
<gender>
  Both
</gender>
<minimum_age>
  3 Years
</minimum_age>
<maximum_age>
  12 Years
</maximum_age>
</eligibility>
<investigator>
<role>
  Principal Investigator
</role>
<name>
  Ioannis M Vlastos, MD
</name>
<affiliation>
<agency>
  Aghia Sophia Children&apos;s Hospital of Athens
</agency>
</affiliation>
</investigator>
<contact>
<name>
  Ioannis M Vlastos, MD
</name>
<phone>
  +306976141680
</phone>
<phone_ext>
</phone_ext>
<email>
  giannisvlastos@yahoo.gr
</email>
</contact>
<location>
<facility>
<name>
  Department of Otolaryngology-Head and Neck Surgery, Aghia Sophia Children&apos;s Hospital of Athens
</name>
<address>
<city>
  Athens
</city>
<state>
</state>
<zip>
</zip>
<country>
  Greece
</country>
</address>
</facility>
<status>
  Recruiting
</status>
<contact>
<name>
  Michael Houlakis, MD, PhD
</name>
<phone>
  +302107467000
</phone>
<phone_ext>
  7309
</phone_ext>
<email>
  houlakis@gmail.com
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Ioannis M Vlastos, MD
</name>
</contact>
</location>
<keyword>
  adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy
</keyword>
<initial_release_date>
  2008-02-27
</initial_release_date>
<last_release_date>
2008-02-27 
</last_release_date>
</clinical_study>
